As of September 2023, APH researcher Baudewijntje Kreukels is the new program leader of Personalized Medicine (PM). She will take over this role from Kristel van Asselt (general practitioner and researcher in the department of General Practice, Amsterdam UMC).
In moving from protocolled care towards personalized care, and with an increasing diversity of treatment trajectories, it is key to enlarge our understanding of how individual characteristics and choices influence the outcome of care.

Baudewijntje Kreukels is a Full Professor at the Department of Medical Psychology and the Center of Expertise on Gender Dysphoria of the Amsterdam UMC.

Her research focuses on the development of gender identity and gender incongruence, and the evaluation of care and treatment for gender incongruence and variations in sex development (differences of sex development, DSD). She was a board member of the World Professional Association for Transgender Health from 2016-2020. She is a member of the steering committee of the European Network for the Investigation of Gender Incongruence (ENIGI) and an associate editor of the International Journal of Transgender Health. She is a principal investigator affiliated to the research institutes Amsterdam Public Health and Reproduction & Development. Since 2020, she has been a member of the program council of Personalized Medicine (Amsterdam Public Health).

Current research interests include aging and effects of hormone treatment on cognitive function and psychological well-being, sexual health in people with gender incongruence and variations of sex development, and the neurobiological substrate of gender incongruence and its treatment.